Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Simon

Showing results (681-690 of 732) with videos related to

Pageof 74
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trialsAlberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
Pediatrics|January 27, 2017
Children's Hospital Characteristics and Readmission MetricsKatherine A Auger, Ronald J Teufel, J Mitchell Harris, et al.
Journal of Hospital Medicine|October 24, 2014
Prevalence and predictors of return visits to pediatric emergency departmentsAyobami T Akenroye, Cary W Thurm, Mark I Neuman, et al.
The Journal of Pediatrics|December 6, 2014
Rates and impact of potentially preventable readmissions at children's hospitalsJames C Gay, Rishi Agrawal, Katherine A Auger, et al.
British Journal of Cancer|September 8, 2017
Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligandsA Almazán-Moga, P Zarzosa, C Molist, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 15, 2011
Resource burden at children's hospitals experiencing surge volumes during the spring 2009 H1N1 influenza pandemicMarion R Sills, Matthew Hall, Harold K Simon, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Journal of the Neurological Sciences|March 22, 2017
Caffeine, creatine, GRIN2A and Parkinson's disease progressionDavid K Simon, Cai Wu, Barbara C Tilley, et al.
Pageof 74

Showing results (681-690 of 732) with videos related to

Sort By:
Pageof 74
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trialsAlberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
Pediatrics|January 27, 2017
Children's Hospital Characteristics and Readmission MetricsKatherine A Auger, Ronald J Teufel, J Mitchell Harris, et al.
Journal of Hospital Medicine|October 24, 2014
Prevalence and predictors of return visits to pediatric emergency departmentsAyobami T Akenroye, Cary W Thurm, Mark I Neuman, et al.
The Journal of Pediatrics|December 6, 2014
Rates and impact of potentially preventable readmissions at children's hospitalsJames C Gay, Rishi Agrawal, Katherine A Auger, et al.
British Journal of Cancer|September 8, 2017
Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligandsA Almazán-Moga, P Zarzosa, C Molist, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 15, 2011
Resource burden at children's hospitals experiencing surge volumes during the spring 2009 H1N1 influenza pandemicMarion R Sills, Matthew Hall, Harold K Simon, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Journal of the Neurological Sciences|March 22, 2017
Caffeine, creatine, GRIN2A and Parkinson's disease progressionDavid K Simon, Cai Wu, Barbara C Tilley, et al.
Pageof 74